Positions I’m Watching: Biotechnology ETFs

By: Stacey Nickens | July 24

Tons of biotechnology companies are tasked with developing a COVID-19 vaccine, making their stocks an appealing buy. However, when one or two of these companies eventually succeed, the others will could see a drop in the value of their stocks. Since none of us can predict the winners, I recommend looking at biotech ETFs. These ETFs hold many of the companies researching vaccines, which might allow you to capitalize on growth in this field. Yet, due to the broad-coverage of ETFs, you could also be more protected from individual company volatility. Some biotech ETFs I am watching are SPDR SP Biotech ETF (XBI) and iShares NASDAQ Biotechnology ETF (IBB).

Learn more about the general market performance this week. 

Disclosures: Past performance is not a guarantee or a reliable indicator of future performance. All securities carry a unique set of risks subject to a variety of factors. There is no guarantee that these investment strategies will work under all market conditions or that they are are suitable for all investors. This material has been distributed solely for informational purposes and should not be considered as individual investment advice or recommendation. Individuals should consult their investment professional prior to making an investment decision.